Quantitative metrics of net proliferation and invasion link biological aggressiveness assessed by MRI with hypoxia assessed by FMISO-PET in newly diagnosed glioblastomas

Cancer Research

Volumn 69, Issue 10, 2009, Pages 4502-4509

  Szeto, Mindy D ^a   Chakraborty, Gargi ^a   Hadley, Jennifer ^a   Rockne, Russ ^a   Muzi, Mark ^a   Alvord Jr , Ellsworth C ^a   Krohn, Kenneth A ^a   Spence, Alexander M ^a   Swanson, Kristin R ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL; GADOLINIUM;

ADULT; AGED; ARTICLE; BRAIN HYPOXIA; CANCER CELL; CELL INVASION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HYPOXIA; MALE; MATHEMATICAL MODEL; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TUMOR GROWTH; TUMOR VOLUME;

ADULT; BRAIN NEOPLASMS; CELL DIVISION; COMPUTER SIMULATION; CONTRAST MEDIA; FEMALE; FLUORINE RADIOISOTOPES; GADOLINIUM; GLIOBLASTOMA; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MISONIDAZOLE; NEOPLASM INVASIVENESS; POSITRON-EMISSION TOMOGRAPHY;

EID: 66249097780     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-3884     Document Type: Article

References (43)

1. Swanson KR, Alvord EC, Jr., Murray JD. Virtual brain tumours (gliomas) enhance the reality of medical imaging and highlight inadequacies of current therapy. Br J Cancer 2002;86:14-18 (Pubitemid 34146334)
2. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987-996 (Pubitemid 40349501)
3. Stupp R, Hegi ME, Gilbert MR, Chakravarti A. Chemoradiotherapy in malignant glioma: standard of care and future directions. J Clin Oncol 2007;25:4127-4136 (Pubitemid 47492957)
4. Silbergeld DL, Rostomily RC, Alvord EC, Jr. The cause of death in patients with glioblastoma is multifactorial: clinical factors and autopsy findings in 117 cases of supratentorial glioblastoma in adults. J Neurooncol 1991;10:179-185
5. Mankoff DA, Peterson LM, Tewson TJ, et al. [18F]fluoroestradiol radiation dosimetry in human PET studies. J Nucl Med 2001;42:679-684
6. Tewson TJ, Krohn KA. PET radiopharmaceuticals: state-of-the-art and future prospects. Semin Nucl Med 1998;28:221-234 (Pubitemid 28371216)
7. Varagnolo L, Stokkel MP, Mazzi U, Pauwels EK. 18F-labeled radiopharmaceuticals for PET in oncology, excluding FDG. Nucl Med Biol 2000;27:103-112 (Pubitemid 30204565)
8. Phelps ME. PET: the merging of biology and imaging into molecular imaging. J Nucl Med 2000;41:661-681 (Pubitemid 30207744)
9. Spence AM, Muzi M, Swanson KR, et al. Regional hypoxia in glioblastoma multiforme quantified with [18F]fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and survival. Clin Cancer Res 2008;14:2623-2630
10. Rasey JS, Grunbaum Z, Magee S, et al. Characterization of radiolabeled fluoromisonidazole as a probe for hypoxic cells. Radiat Res 1987;111:292-304. (Pubitemid 17156952)
11. Rajendran JG, Wilson DC, Conrad EU, et al. [(18)F]FMISO and [(18)F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression. Eur J Nucl Med Mol Imaging 2003;30:695-704. (Pubitemid 36612952)
12. Rajendran JG, Mankoff DA, O'Sullivan F, et al. Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging. Clin Cancer Res 2004;10:2245-2252 (Pubitemid 38445681)
13. Tsang RW, Fyles AW, Milosevic M, et al. Interrelationship of proliferation and hypoxia in carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2000;46:95-99 (Pubitemid 30021486)
14. Brown JM. Therapeutic targets in radiotherapy. Int J Radiat Oncol Biol Phys 2001;49:319-326 (Pubitemid 32120230)
15. Fyles AW, Milosevic M, Wong R, et al. Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiother Oncol 1998;48:149-156 (Pubitemid 28423786)
16. Kleihues P, Ohgaki H. Primary and secondary glioblastomas: from concept to clinical diagnosis. Neuro-oncol 1999;1:44-51.
17. Dachs GU, Tozer GM. Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation. Eur J Cancer 2000;36:1649-1660 (Pubitemid 30616369)
18. Swanson KR, Bridge C, Murray JD, Alvord EC, Jr. Virtual and real brain tumors: using mathematical modeling to quantify glioma growth and invasion. J Neurol Sci 2003;216:1-10. (Pubitemid 37371859)
19. Swanson KR. Mathematical modeling of the growth and control of tumors [PhD]: University of Washington; 1999.
20. Swanson KR, Rostomily RC, Alvord EC, Jr. A mathematical modelling tool for predicting survival of individual patients following resection of glioblastoma: a proof of principle. Br J Cancer 2008;98:113-119
21. Murray JD. Mathematical biology I: an introduction. 3rd ed. New York: Springer-Verlag; 2002.
22. Burgess PK, Kulesa PM, Murray JD, Alvord EC, Jr. The interaction of growth rates and diffusion coefficients in a three-dimensional mathematical model of gliomas. J Neuropathol Exp Neurol 1997;56:704-713 (Pubitemid 27463105)
23. Swanson KR, Alvord EC, Jr., Murray JD. A quantitative model for differential motility of gliomas in grey and white matter. Cell Prolif 2000;33:317-329
24. Mandonnet E, Delattre JY, Tanguy ML, et al. Continuous growth of mean tumor diameter in a subset of grade II gliomas. Ann Neurol 2003;53:524-528 (Pubitemid 36373265)
25. Swanson KR, Alvord EC, Jr. A biomathematical and pathological analysis of an untreated glioblastoma. Helsinki (Finland): 7th European Congress of Neuropathology; 2002.
26. Pallud J, Mandonnet E, Duffau H, et al. Prognostic value of initial magnetic resonance imaging growth rates for World Health Organization grade II gliomas. Ann Neurol 2006;60:380-383 (Pubitemid 44520241)
27. Harpold HL, Alvord EC, Jr., Swanson KR. The evolution of mathematical modeling of glioma proliferation and invasion. J Neuropathol Exp Neurol 2007;66:1-9. (Pubitemid 46066783)
28. Lim JL, Berridge MS. An efficient radiosynthesis of [18F] fluoromisonidazole. Appl Radiat Isot 1993;44:1085-1091 (Pubitemid 23214211)
29. Swanson KR, Chakraborty G, Wang CH, et al. Complementary but distinct roles for MRI and 18F-fluoromisonidazole PET in the assessment of human glioblastomas. J Nucl Med 2009;50:36-44.
30. Ashburner J, Flandin G, Henson R, et al. Statistical Parametric Mapping (SPM). Functional Imaging Laboratory. 5th ed. Wellcome Department of Imaging Neuroscience: Institute of Neurology; 2005.
31. MATLAB. 2007a edition. Natick (MA): The MathWorks, Inc.; 2007.
32. Rajendran JG, Krohn KA. Imaging tumor hypoxia. In: Bailey DL, Townsend DW, Valk PE, Maisey MN, editors. Positron emission tomography, principles and practice. London: Springer-Verlag; 2002. p. 689-696
33. Anderson AR, Weaver AM, Cummings PT, Quaranta V. Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment. Cell 2006;127:905-915
34. Silva AC, Carvalho PC, Gattass M. Diagnosis of lung nodule using semivariogram and geometric measures in computerized tomography images. Comput Methods Programs Biomed 2005;79:31-38 (Pubitemid 40800400)
35. Kleihues P, Louis DN, Scheithauer BW, et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 2002;61:215-25; discussion 26-29
36. Cher LM, Murone C, Lawrentschuk N, et al. Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies. J Nucl Med 2006;47:410-418 (Pubitemid 46768482)
37. Rasey JS, Nelson NJ, Chin L, Evans ML, Grunbaum Z. Characteristics of the binding of labeled fluoromisonidazole in cells in vitro. Radiat Res 1990;122:301-308 (Pubitemid 20214420)
38. Rasey JS, Koh WJ, Evans ML, et al. Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients. Int J Radiat Oncol Biol Phys 1996;36:417-428 (Pubitemid 126745247)
39. Brizel DM, Dodge RK, Clough RW, Dewhirst MW. Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome. Radiother Oncol 1999;53:113-117
40. Lally BE, Rockwell S, Fischer DB, Collingridge DR, Piepmeier JM, Knisely JP. The interactions of polarographic measurements of oxygen tension and histological grade in human glioma. Cancer J 2006;12:461-466 (Pubitemid 46026194)
41. Swanson KR, Alvord EC, Jr., Murray JD. Dynamics of a model for brain tumors reveals a small window for therapeutic intervention. Discrete Cont Dyn B 2004;4:289-295 (Pubitemid 38202967)
42. Dence CS, Ponde DE, Welch MJ, Lewis JS. Autoradiographic and small-animal PET comparisons between 18F-FMISO, 18F-FDG, 18F-FLT and the hypoxic selective 64Cu-ATSM in a rodent model of cancer. Nucl Med Biol 2008;35:713-720
43. Churchill SW, Zajic SC. Prediction of fully developed turbulent convection with minimal explicit empiricism. AIChE J 2002;48:927-940 (Pubitemid 36173039)